Howard Bailey Securities’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-540
Closed -$210K 148
2025
Q2
$210K Sell
540
-209
-28% -$84.1K 0.06% 144
2025
Q1
$326K Sell
749
-471
-39% -$189K 0.11% 104
2024
Q4
$450K Buy
1,220
+437
+56% +$183K 0.17% 79
2024
Q3
$407K Buy
+783
New +$418K 0.15% 91

Other funds holding ELV

Howard Bailey Securities's ELV Position: Q3 2025 in Review

Howard Bailey Securities sold out of Elevance Health (ELV) in Q3 2025, closing a stake of 540 shares — an estimated $210K sold.

Howard Bailey Securities first reported a position in ELV in Q3 2024 and held it in 4 quarters. The position peaked at $450K in Q4 2024. 1,511 funds tracked by Wall St. Rank hold ELV as of Q3 2025.

  • Howard Bailey Securities reported no remaining Elevance Health position as of Q3 2025 after selling out during the quarter.
  • Howard Bailey Securities sold 540 Elevance Health shares in Q3 2025, an estimated $210K.
  • Howard Bailey Securities first reported a position in Elevance Health in Q3 2024 and held it in 4 quarters.
  • Howard Bailey Securities's Elevance Health position peaked at $450K in Q4 2024.
  • 1,511 funds tracked by Wall St. Rank held Elevance Health as of Q3 2025.

Based on Howard Bailey Securities's 13F filing for Q3 2025, filed 4 Nov 2025.